Tissue vs Liquid Biopsies for Cancer Detection: Ethical Issues

Journal of Bioethical Inquiry 16 (4):551-557 (2019)
  Copy   BIBTEX

Abstract

Cancer is the second leading cause of death in developed countries, making it a global public health problem. In this scenario, early detection is the key to successful treatment. Tissue biopsy, the current gold standard for cancer diagnosis, offers reliable results, but it is feasible only when the mass becomes detectable. On the other hand liquid biopsy, a promising experimental system, not yet implemented within clinical practice, allows early detection as its functioning relies on the analysis of body fluids. Yet, its results are less reliable if compared to those of tissue biopsy as, for instance, false positives and false negatives might occur. Despite technical features, the tradeoff between a reliable diagnosis available at a later time and a potentially less reliable diagnosis available at an early stage poses significant ethical challenges in the clinical scenario which involve, among other aspects, informed consent, communication, and patient-physician encounter.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 74,480

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The Ethical Issues of Terminal Cancer Patients.Wenhao Su - 2006 - Philosophy and Culture 33 (4):5-15.

Analytics

Added to PP
2019-11-15

Downloads
3 (#1,305,523)

6 months
1 (#417,474)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations